Ewing's tumors over the age of 40 - A retrospective analysis of 47 patients treated according to the international clinical trials EICESS 92 and EURO-E.W.I.N.G. 99

Onkologie

Volumn 31, Issue 12, 2008, Pages 657-663

  Pieper, Sebastian ^a   Ranft, Andreas ^a   Braun Munzinger, Gabriele ^a   Jürgens, Heribert ^a   Paulussen, Michael ^b   Dirksen, Uta ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Adults; Chemotherapy; Ewing's tumor; Radiotherapy; Surgery

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; TREOSULFAN; VINCRISTINE;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW METASTASIS; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESOPHAGITIS; EWING SARCOMA; FEMALE; FEVER; FOLLOW UP; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; PREOPERATIVE RADIOTHERAPY; SIDE EFFECT; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; THERAPY DELAY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VEIN OCCLUSION;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; FEMALE; GERMANY; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SARCOMA, EWING'S; SURVIVAL ANALYSIS; SURVIVAL RATE; SWITZERLAND; TREATMENT OUTCOME;

EID: 57449106661     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000165361     Document Type: Article

References (54)

1. Ewing J: Diffuse endothelioma of bone. Proc N Y Pathol Soc 1921;21:17-24.
2. Nesbit ME Jr, Gehan EA, Burgert EO Jr, Vietti TJ, Cangir A, Tefft M, Evans R, Thomas P, Askin FB, Kissane JM, Pritchard DJ, Herrmann J, Neff J, Makley JT, Gilula L: Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the first intergroup study. J Clin Oncol 1990;8:1664-1674.
3. Angervall L, Enzinger FM: Extraskeletal neoplasm resembling Ewing's sarcoma. Cancer 1975;36:240-251.
4. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Thomas G: The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994; 331:294-299.
5. Rosen G, Caparros B, Mosende C, McCormick B, Huvos AG, Marcove RC: Curability of Ewing's sarcoma and considerations for future therapeutic trials. Cancer 1978;41:888-899.
6. Kinsella TJ, Miser JS, Waller B, Venzon D, Glatstein E, Weaver-McClure L, Horowitz ME: Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy. Int J Radiat Oncol Biol Phys 1991;20:389-395.
7. Craft AW, Cotterill SJ, Bullimore JA, Pearson D: Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer 1997;33:1061-1069.
8. Jürgens H, Exner U, Gadner H, Harms D, Michaelis J, Sauer R, Treuner J, Voûte T, Winkelmann W, Winkler K, Göbel U: Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer 1988;61:23-32.
9. Gasparini M, Lombardi F, Gianni C, Fossati-Bellani F: Localized Ewing's sarcoma: results of integrated therapy and analysis of failures. Eur J Cancer Clin Oncol 1981;17:1205-1209.
10. Zucker JM, Henry-Amar M, Sarrazin D, Blache R, Patte C, Schweisguth O: Intensive systemic chemotherapy in localized Ewing's sarcoma in childhood: a historical trial. Cancer 1983;52:415-423.
11. Deméocq F, Carton P, Patte C, Oberlin O, Sarrazin D, Lemerle J: Traitement du sarcome d'Ewing par chimiotherapie initiale intensive. Presse Med 1984;13:717-721.
12. Grier HE: The Ewing family of tumors: Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am 1997;44:991-1004.
13. Burgert EO Jr, Nesbit ME, Garnsey LA, Gehan EA, Herrmann J, Vietti TJ, Cangir A, Tefft M, Evans R, Thomas P, Askin FB, Kissane JM, Pritchard DJ, Neff J, Makley JT, Gilula L: Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS II. J Clin Oncol 1990;8:1514-1524.
14. Evans RG, Nesbit ME, Gehan EA, Garnsey LA, Burgert EO Jr, Vietti TJ, Cangir A, Tefft M, Thomas P, Askin FB, Kissane JM, Pritchard DJ, Neff J, Makley JT, Gilula L: Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study. J Clin Oncol 1991;9:1173-1180.
15. Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Müller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Göbel U, Treuner J, Voûte PA, Zoubek A, Gadner H, Jürgens H: Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001;19:1818-1829.
16. Strauss SJ, McTiernan A, Driver D, Hall-Craggs M, Sandison A, Cassoni AM, Kilby A, Michelagnoli M, Pringle J, Cobb J, Briggs T, Cannon S, Witt J, Whelan JS: Single center experience of a new intensive induction therapy for Ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties. J Clin Oncol 2003;21:2974-2981.
17. Anders Kolb E, Kushner BH, Gorlick R, Laverdiere C, Healey JH, LaQuaglia MP, Huvos AG, Qin J, Vu HT, Wexler L, Wolden S, Meyers PA: Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol 2003;21:3423-3430.
18. Schuck A, Ahrens S, Paulussen M, Kuhlen M, Könemann S, Rübe C, Winkelmann W, Kotz R, Dunst J, Willich N, Jürgens H: Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiation Oncol Biol Phys 2003;55:168-177.
19. Paulussen M, Ahrens S, Braun-Munzinger G, Craft AW, Dockhorn-Dworniczak B, Dörffel W, Dunst J, Fröhlich B, Göbel U, Häussler M, Klingebiel T, Koscielniak, Mittler U, Rübe C, Winkelmann W, Voûte PA, Zoubek A, Jürgens H: EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study) - preliminary results. Klin Päd 1999;211:276-283.
20. Juergens C, Weston C, Lewis I, Whelan J, Paulussen M, Oberlin O, Michon J, Zoubek A, Juergens H, Craft A: Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer 2006;47:22-29.
21. Jürgens H, Craft AW: Euro-E.W.I.N.G.99, European Ewing Tumour Working Initiative of National Groups. Ewing Tumour Studies 1999, EE99, study manual.
22. Oberlin O, Habrand JL: Ewing's sarcoma: towards a common protocol for adults and children. Cancer Radiother 2000;4(suppl 1):141s-144s.
23. Rodriguez-Galindo C, Spunt SL, Pappo AS: Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol 2003;40:276-287.
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
25. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 1977;35:1-39.
26. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
27. Peto R, Peto J: Asymptotically efficient rank invariant test procedures (with discussion). J Roy Stat Soc A 1972;135:185-206.
28. Cox DR: Regression models and life tables (with discussion). J Roy Stat Soc B 1972;34:187-220.
29. Salzer-Kuntschik M, Delling D, Beron G, Sigmund R: Morphological grades of regression on osteosarcoma after polychemotherapy: Study COSS 80. J Cancer Res Clin Oncol 1983;106:21-24.
30. Hense HW, Ahrens S, Paulussen M, Lehnert M, Jürgens H: Descriptive epidemiology of Ewing's tumor-analysis of German patients from (EI)Cess 1980-1997. Klin Padiatr 1999;211:271-275.
31. Cotterill SJ, Parker L, Malcolm AJ, Reid M, More L, Craft AW: Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry. Br J Cancer 2000;83:397-403.
32. Sinkovics JG, Plager C, Ayala AG, Lindberg LD, Samuels ML: Ewing sarcoma: its course and treatment in 50 adult patients. Oncology 1980;37:114-119.
33. Picci P, Bohling T, Bacci G, Ferrari S, Sangiorgi L, Mercuri M, Ruggieri P, Manfrini M, Ferraro A, Casadei R, Benassi MS, Mancini AF, Rosito P, Cazzola A, Barbieri E, Tienghi A, Brach del Prever A, Comandone A, Bacchini P, Bertoni F: Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 1997;15:1553-1559.
34. Siegel RD, Ryan LM, Antman KH: Adults with Ewing's sarcoma: an analysis of 16 patients at the Dana-Farber Cancer Institute. Am J Clin Oncol 1988;11:614-617.
35. Verrill MW, Judson IR, Harmer CL, Fisher C, Thomas JM, Wiltshaw E: Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children? J Clin Oncol 1997;15:2611-2621.
36. Klassen R, Sastregarau X, Aurias A, et al.: Sarcoma d'Ewing osseoux de l'adulte. Etude anatomoclinique de 30 observations. Bull Cancer 1992;79:161-167.
37. Fizazi K, Dohollou N, Blay JY, Guérin S, Le Cesne A, André F, Pouillart P, Tursz T, Binh Bui N: Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients. J Clin Oncol 1998;16:3736-3743.
38. Bacci G, Balladelli A, Forni C, Ferrari S, Longhi A, Bacchini P, Alberghini M, Fabbri N, Benassi MS, Briccoli A, Picci P: Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60. Cancer 2007;109:780-786.
39. Ladenstein R, Whelan J, Oberlin O, Weston C, Jürgens H: Multivariate analysis based risk grouping of Ewing tumours (ET) with extrapulmonary metastatic disease (EPMD): final results from the EURO-E.W.I.N.G. 99 study. ASCO Ann Meet Proc Part I, J Clin Oncol 2007;25(suppl):541 (abstr 9562).
40. Kushner BH, Meyers PA, Gerald WL, Healey JH, La Quaglia MP, Boland P, Wollner N, Casper ES, Aledo A, Heller G: Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J Clin Oncol 1995;13:2796-2804.
41. Paulussen M, Braun-Munzinger G, Burdach S, Deneke S, Dunst J, Fellinger E, Gobel U, Mittler U, Treuner J, Voûte PA, et al.: Results of treatment of primary exclusively pulmonary metastatic Ewing sarcoma. A retrospective analysis of 41 patients. Klin Pad 1993;205:210-216.
42. Paulussen M, Ahrens S, Burdach S, Craft A, Dockhorn-Dworniczak B, Dunst J, Fröhlich B, Winkelmann W, Zoubek A, Jürgens H: Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 1998;9:275-281.
43. Cotterill SJ, Ahrens S, Paulussen M, Jürgens HF, Voûte PA, Gadner H, Craft AW: Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000;18:3108-3114.
44. Bacci G, Ferrari S, Bertone F, Rimondini S, Longhi A, Bacchini P, Forni C, Manfrini M, Donati D, Picci P: Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients as the Instituto Ortopedico Rizzoli. J Clin Oncol 2000;18:4-11.
45. Miser JS, Kinsella TJ, Triche TJ, Steis R, Tsokos M, Wesley R, Horvath K, Belasco J, Longo DL, Glatstein E, Israel MA: Treatment of peripheral neuroepithelioma in children and young adults. J Clin Oncol 1987;5:1752-1758.
46. Hayes FA, Thompson EI, Parvey L, Rao B, Kun L, Parham D, Hustu HO: Metastatic Ewing's sarcoma: remission induction and survival. J Clin Oncol 1987;5:1199-1204.
47. Jürgens H, Bier V, Harms D, Beck J, Brandeis W, Etspüler G, Gadner H, Schmidt D, Treuner J, Winkler K, Göbel U: Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients. Cancer 1988;61:349-357.
48. Marina NM, Etcubanas E, Parham DM, Bowman LC, Green A: Peripheral primitive neuroectodermal tumor (peripheral neuroepithelioma) in children. A review of the St. Jude experience and controversies in diagnosis and management. Cancer 1989;64:1952-1960.
49. Kushner BH, Hajdu SI, Gulati SC, Erlandson RA, Exelby PR, Liebermann PH: Extracranial primitive neuroectodermal tumors, the Memorial Sloan-Kettering Cancer Center experience. Cancer 1991;67:1825-1829.
50. Sailer SL, Harmon DC, Mankin HJ, Truman JT, Suit HD: Ewing's sarcoma: surgical resection as a prognostic factor. Int J Radiat Oncol Biol Phys 1988;15:43-52.
51. Bacci G, Toni A, Avella M, Manfrini M, Sudanese A, Ciaroni D, Boriani S, Emiliani E, Campanacci M: long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 1989;63:1477-1486.
52. Meyers PA, Wunder J, Healey JM, et al.: Ewing's sarcoma/primitive neuroectodermal tumor of bone: histological response to preoperative chemotherapy predicts event-free survival. Proc Am Soc Clin Oncol 1995;14:441.
53. Oberlin O, Patte C, Demeocq F, Lacombe MJ, Brunat-Mentigny M, Demaille MC, Tron P, Bui BN, Lemerle J: The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma. Eur J Cancer Clin Oncol 1985;21:463-467.
54. Juergens C, Weston C, Lewis I, Whelan J, Paulussen M, Oberlin O, Michon J, Zoubek A, Juergens H, Craft A: Safety assessment of intensive induction with vincristine, ifosfomide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G 99 clinical trial. Pediatr Blood Cancer. 2006;47:22-29.